Registration is now open for Breakthrough T1D’s Walk to Cure Diabetes, the largest diabetes fundraising Walk in San Diego. More than 4,000 walkers representing local families, companies, schools, and other organizations are expected to participate in the 25th annual Breakthrough T1D Walk to Cure Diabetes on Saturday November 10th in Balboa Park. This year’s Western theme, Give Diabetes the Boot, will be highlighted as many walkers wear their favorite Wild West gear. The goal for the Walk to Cure Diabetes is to raise $700,000 for research to find a cure for diabetes and its complications.
Registration recently opened and 96 family, school and corporate teams have already registered in addition to 36 individuals. To register Click Here or call the Breakthrough T1D office at 858-597-0240.
The 2012 Presenting Walk Sponsor is Amylin Pharmaceuticals while Shire Regenerative Medicine is this year’s Gold Sponsor. Silver Sponsors include Emerson Network Power, GEICO, GKN Aerospace, The Genomics Institute of the Novartis Research Foundation, Profil Institute for Clinical Research and QUALCOMM. In addition to corporate support, companies and entire families from kids to grandparents form Walk teams and take part in the fundraising efforts to raise funds for diabetes research. Walkers can also participate as Individual Walkers.
Breakthrough T1D Walks are held in more than 200 cities worldwide. Nearly 500,000 people nationally walked last year and raised $86 million for research to cure, treat and prevent type 1 diabetes.
JDRF’s Walk to Cure Diabetes Elite Principal Partners are: Advance Auto Parts and Ford Motor Company. The Breakthrough T1D Walk to Cure Diabetes Principal Partners include Hy-Vee, Marshall’s, Roche Accu-Chek and Walgreens.
About Breakthrough T1D
Breakthrough T1D is the leader in research leading to a cure for T1D in the world. It sets the global agenda for diabetes research, and is the largest charitable funder and advocate of diabetes science worldwide.
The mission of Breakthrough T1D is to find a cure for diabetes and its complications through the support of research. Type 1 diabetes is an autoimmune disease that strikes children and adults, and can be fatal. Until a cure is found, people with type 1 diabetes have to test their blood sugar and give themselves insulin injections multiple times or use a pump ““ each day, every day of their lives. And even with that intensive care, insulin is not a cure for diabetes, nor does it prevent its potential and devastating complications, which may include kidney failure, blindness, heart disease, stroke and amputation.
Since its founding in 1970 by parents of children with T1D, Breakthrough T1D has awarded more than $1.5 billion to diabetes research, including $107 million last year. More than 80 percent of Breakthrough T1D’s expenditures directly support research and research-related education.
For more information, visit the Breakthrough T1D web site at www.jdrfsd.org or call 858-597-0240.
